{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:50:50Z","timestamp":1792795850321,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.nbd.2023.106112","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T18:49:32Z","timestamp":1680202172000},"page":"106112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Systematic assessment of plasma biomarkers in spinocerebellar ataxia"],"prefix":"10.1016","volume":"181","author":[{"given":"Xue-Ning","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106112_bb0005","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Move. Disorder.\u202f: Off. J. Move. Disorder Soc."},{"key":"10.1016\/j.nbd.2023.106112_bb0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","article-title":"Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy","volume":"93","author":"Chouliaras","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106112_bb0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2023.106112_bb0020","doi-asserted-by":"crossref","first-page":"e1276","DOI":"10.1212\/WNL.0000000000012598","article-title":"Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical Spectrum: cross-sectional and longitudinal associations","volume":"97","author":"Eikelboom","year":"2021","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nbd.2023.106112_bb0025","first-page":"2439","article-title":"Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3","volume":"29","author":"Garcia-Moreno","year":"2022","journal-title":"Eur. J."},{"key":"10.1016\/j.nbd.2023.106112_bb0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106112_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41398-020-01036-5","article-title":"Common and distinct patterns of intrinsic brain activity alterations in major depression and bipolar disorder: voxel-based meta-analysis","volume":"10","author":"Gong","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106112_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/alz.12377","article-title":"Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: the CABLE study","volume":"18","author":"Hu","year":"2022","journal-title":"Alzheimer\u2019s & Dementia\u202f: J. Alzheimer\u2019s Assoc."},{"key":"10.1016\/j.nbd.2023.106112_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3988\/jcn.2021.17.2.187","article-title":"Clinical, imaging, and laboratory markers of Premanifest spinocerebellar Ataxia 1, 2, 3, and 6: a systematic review","volume":"17","author":"Kim","year":"2021","journal-title":"J. Clin. Neurol. (Seoul, Korea)"},{"key":"10.1016\/j.nbd.2023.106112_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Disease Prim."},{"key":"10.1016\/j.nbd.2023.106112_bb0055","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.nbd.2023.106112_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/glia.20622","article-title":"GFAP promoter elements required for region-specific and astrocyte-specific expression","volume":"56","author":"Lee","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2023.106112_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awt162","article-title":"The role of the posterior cingulate cortex in cognition and disease","volume":"137","author":"Leech","year":"2014","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-019-0338-0","article-title":"Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3","volume":"14","author":"Li","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2023.106112_bb0075","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fneur.2020.00902","article-title":"Collaborative efforts for spinocerebellar Ataxia research in the United States: CRC-SCA and READISCA","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0080","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/nn.4661","article-title":"Viewpoints: how the hippocampus contributes to memory, navigation and cognition","volume":"20","author":"Lisman","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2023.106112_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","article-title":"Dynamic changes of CSF sTREM2 in preclinical Alzheimer\u2019s disease: the CABLE study","volume":"15","author":"Ma","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2023.106112_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106112_bb0100","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106112_bb0105","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/mds.28738","article-title":"Systematic assessment of 10 biomarker candidates focusing on \u03b1-Synuclein-related disorders","volume":"36","author":"Schulz","year":"2021","journal-title":"Move. Disorder.\u202f: Off. J. Move. Disorder Soc."},{"key":"10.1016\/j.nbd.2023.106112_bb0110","doi-asserted-by":"crossref","first-page":"13517","DOI":"10.1038\/s41598-021-92855-z","article-title":"Serum neurofilament light chain as a severity marker for spinocerebellar ataxia","volume":"11","author":"Shin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106112_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s & Dementia\u202f: J. Alzheimer\u2019s Assoc."},{"key":"10.1016\/j.nbd.2023.106112_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nbd.2010.08.016","article-title":"Amyloid precursor-like protein 2 cleavage contributes to neuronal intranuclear inclusions and cytotoxicity in spinocerebellar ataxia-7 (SCA7)","volume":"41","author":"Takahashi-Fujigasaki","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106112_bb0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1474-4422(19)30354-0","article-title":"Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study","volume":"18","author":"van der Ende","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0130","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/mds.28819","article-title":"Gene therapy for Polyglutamine spinocerebellar ataxias: advances, challenges, and perspectives","volume":"36","author":"V\u00e1zquez-Mojena","year":"2021","journal-title":"Move. Disorder.\u202f: Off. J. Move. Disorder Soc."},{"key":"10.1016\/j.nbd.2023.106112_bb0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0140","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00415-018-8893-9","article-title":"Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study","volume":"265","author":"Wilke","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0145","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911803","article-title":"Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice","volume":"12","author":"Wilke","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2023.106112_bb0150","doi-asserted-by":"crossref","first-page":"e1985","DOI":"10.1212\/WNL.0000000000200257","article-title":"Levels of Neurofilament light at the Preataxic and ataxic stages of spinocerebellar Ataxia type 1","volume":"98","author":"Wilke","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106112_bb0155","doi-asserted-by":"crossref","first-page":"e2404","DOI":"10.1212\/WNL.0000000000012945","article-title":"Association of the Level of Neurofilament light with disease severity in patients with spinocerebellar Ataxia type 2","volume":"97","author":"Yang","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106112_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.779890","article-title":"Evaluation of blood glial fibrillary acidic protein as a potential marker in Huntington\u2019s disease","volume":"12","author":"You","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2023.106112_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40035-021-00275-w","article-title":"Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia","volume":"10","author":"Zhu","year":"2021","journal-title":"Translat. Neurodegenerat."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123001262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123001262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:37:41Z","timestamp":1760852261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123001262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":33,"alternative-id":["S0969996123001262"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106112","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic assessment of plasma biomarkers in spinocerebellar ataxia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106112"}}